Posted Feb. 22, 2012 at 9:25 a.m.
Research Triangle Park, N.C. — As three key clinical trials continue, Targacept does not yet have any approved products. CFO Alan Musso notes that the company has enough cash to last through the end of 2014....Copyright 2013 MedCity. All rights reserved.
2012 shaping up as crucial year for WS-based Targacept
Post a comment
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — As three key clinical trials continue, Targacept does not yet have any approved products. CFO Alan Musso notes that the company has enough cash to last through the end of 2014....Copyright 2013 MedCity. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too
ArchiveSocial, a new Durham success story, brings home international award
Durham's high-tech infrastructure, talent lure Virginia company
Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows















